Heart Failure: Stages and Classes
Description

Leaning Objectives
Upon completion of this activity, you should be able to: 

  1. Evaluate the epidemiology, risk factors, comorbidities, and community aspects associated with HF to determine best practices for care. 
  2. Distinguish pathophysiologic characteristics of current classifications of phenotypes when diagnosing HF to analyze best HF risk stratification, prevention, and management strategies. 

Faculty

Alison Bailey, MD, FACC (Chair)

West Virginia University

Morgantown, West Virginia

Disclosure

Consultant Fees/Honoraria: BMS, Medtronic, OptumRx

 

Target Audience 
The primary target audience for this education are members of the HF Care Team, including physicians, advanced practice providers (APPs), PharmDs, and other HCPs.

 

Important Dates  
Date of Release: April 30, 2026
Term of Approval/Date of Expiration: April 30, 2027

Acknowledgement  
This activity is supported by an unrestricted educational grant from Bayer AG.
 

Summary
Availability:
On-Demand
Access expires on Apr 30, 2027
Cost:
FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By